Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 864 participants.

Also called NCT07476898

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 864 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07476898
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07476898. Randomized; no masking; primary purpose treatment. Start 2026-03-01 (anticipated); primary completion 2028-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window
Acronym
TIME-MINOR
Condition
Stroke
Intervention (Drug)
Tenecteplase (0.25mg/kg)
Intervention (Drug)
Standard Medical Management
Lead sponsor
First Hospital of China Medical University (class: other)

Record details

Record id
cardio:ct-nct07476898
Content hash
aef02ab8859a90412a4e376e11d255fd970d446b16d5f7f3acbf1ac340faa809